Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isler

Showing results (801-810 of 859) with videos related to

Pageof 86
Sort By:
International Journal of Pharmaceutics|March 21, 2022
Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progressionLeonardo Delello Di Filippo, Jonatas Lobato Duarte, Juliana Hofstätter Azambuja, et al.
Journal of Clinical and Translational Science|February 27, 2023
DEIA is essential to advance the goals of translational science: Perspectives from NCATSShadab F Hussain, Amanda L Vogel, Jessica M Faupel-Badger, et al.
Journal of Internal Medicine|April 7, 2026
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritisKristina Lend, Jos W R Twisk, Frieda A Koopman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2023
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled TrialKristina Lend, Frieda A Koopman, Jon Lampa, et al.
Arthritis Research & Therapy|July 27, 2025
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohortTahzeeb Fatima, Yuan Zhang, Georgios K Vasileiadis, et al.
The Review of Scientific Instruments|November 29, 2014
Probing the plasma near high power wave launchers in fusion devices for static and dynamic electric fields (invited)C C Klepper, E H Martin, R C Isler, et al.
JAMA Network Open|May 13, 2020
Association Between Prenatal Exposure to Alcohol and Tobacco and Neonatal Brain Activity: Results From the Safe Passage StudyLauren C Shuffrey, Michael M Myers, Joseph R Isler, et al.
Plos One|August 28, 2025
Low Th2 and high PD1+ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritisTilia Selldén, Kerstin Andersson, Inger Gjertsson, et al.
BMJ Open|December 1, 2012
Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled studyMichelle Ghert, Benjamin Deheshi, Ginger Holt, et al.
Frontiers in Immunology|June 17, 2021
Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Pageof 86

Showing results (801-810 of 859) with videos related to

Sort By:
Pageof 86
International Journal of Pharmaceutics|March 21, 2022
Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progressionLeonardo Delello Di Filippo, Jonatas Lobato Duarte, Juliana Hofstätter Azambuja, et al.
Journal of Clinical and Translational Science|February 27, 2023
DEIA is essential to advance the goals of translational science: Perspectives from NCATSShadab F Hussain, Amanda L Vogel, Jessica M Faupel-Badger, et al.
Journal of Internal Medicine|April 7, 2026
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritisKristina Lend, Jos W R Twisk, Frieda A Koopman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2023
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled TrialKristina Lend, Frieda A Koopman, Jon Lampa, et al.
Arthritis Research & Therapy|July 27, 2025
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohortTahzeeb Fatima, Yuan Zhang, Georgios K Vasileiadis, et al.
The Review of Scientific Instruments|November 29, 2014
Probing the plasma near high power wave launchers in fusion devices for static and dynamic electric fields (invited)C C Klepper, E H Martin, R C Isler, et al.
JAMA Network Open|May 13, 2020
Association Between Prenatal Exposure to Alcohol and Tobacco and Neonatal Brain Activity: Results From the Safe Passage StudyLauren C Shuffrey, Michael M Myers, Joseph R Isler, et al.
Plos One|August 28, 2025
Low Th2 and high PD1+ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritisTilia Selldén, Kerstin Andersson, Inger Gjertsson, et al.
BMJ Open|December 1, 2012
Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled studyMichelle Ghert, Benjamin Deheshi, Ginger Holt, et al.
Frontiers in Immunology|June 17, 2021
Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Pageof 86